ORGANIZATION

Japan Drug Industry Vows Further Efforts in Academic Collaboration after Honjo’s Nobel Prize

October 3, 2018
The Japan Pharmaceutical Manufacturers Association (JPMA) on October 2 issued a statement on the 2018 Nobel Prize in medicine awarded to Kyoto University Prof. Tasuku Honjo, pledging that the industry will work to further deepen collaborations with academia to deliver…

To read the full story

Related Article

ORGANIZATION

By Reiji Anasako

Kyowa Hakko Kirin’s first and only Rituxan (rituximab) biosimilar in Japan is showing a faster-than-expected uptake in the market, with the company racking up 4.3 billion yen from the cancer drug in 2018, far beyond its initial 3.2 billion yen…

Members of a key reimbursement policy panel appear to be becoming more and more open to the industry’s call for…

By Philip Carrigan

With a cursory glance, recruitment is easily defined. We’re here to help place candidates into the vacancies our clients need to fill. Armed with a pen and paper, you could even map out the process.• We study the market• We…

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…